Use of Viral Resistance Patterns to Antiretroviral Drugs in Optimising Selection of Drug Combinations and Sequences
- 1 August 1996
- journal article
- research article
- Published by Springer Nature in Drugs
- Vol. 52 (2), 168-185
- https://doi.org/10.2165/00003495-199652020-00002
Abstract
No abstract availableKeywords
This publication has 90 references indexed in Scilit:
- Treatment with Lamivudine, Zidovudine, or Both in HIV-Positive Patients with 200 to 500 CD4+ Cells per Cubic MillimeterNew England Journal of Medicine, 1995
- In vivo emergence of HIV-1 variants resistant to multiple protease inhibitorsNature, 1995
- Reduction Of The In Vitro Activity Of A77003, An Inhibitor Of Human Immunodeficiency Virus Protease, By Human Serum 1 Acid GlycoproteinThe Journal of Infectious Diseases, 1995
- Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infectionNature, 1995
- Viral dynamics in human immunodeficiency virus type 1 infectionNature, 1995
- Genotypic And Phenotypic Analysis Of Human Immunodeficiency Virus Type 1 Isolates From Patients On Prolonged Stavudine TherapyThe Journal of Infectious Diseases, 1994
- Correlates of zidovudine phosphorylation with markers of HIV disease progression and drug toxicityAIDS, 1994
- Quasispecies dynamics and the emergence of drug resistance during zidovudine therapy of HIV infectionAIDS, 1994
- Zidovudine-resistant variants of HIV-1 in brainThe Lancet, 1993
- Development and significance of zidovudine resistance in children infected with human immunodeficiency virusThe Journal of Pediatrics, 1993